Results 41 to 50 of about 129 (94)

Botulinum toxin treatment in a resource-limited setting: Experiences from a public institution in a developing country [PDF]

Biomedica
Panesso GA, Martínez JD, Velasco A, Forero S, Perdomo D, Villamil Á, González ER, Jiménez CA.   +7 more
europepmc   +1 more source

[Teratoid Wilms tumor in an adult: A case report]. [PDF]

Rev Med Inst Mex Seguro Soc
Hernández-Marchena YN, González-Medina WE, Bolado-García PB, Surur-Zaibak EE, Balderas YO, Hernández-Valadez OF, Marrufo-Solís V, Luna HDL, García-Saury K, Méndez-Gutierrez J.   +9 more
europepmc   +1 more source

Inteligencia artificial en atención primaria: efectos y controversias sociales. Revisión sistemática de la bibliografía. [PDF]

Aten Primaria
Prat-Carreño M, Umaña V, Bermejo V, Vallès-Peris N.   +3 more
europepmc   +1 more source

Development of an instrument to measure the cultural competence of health care workers. [PDF]

Rev Saude Publica, 2020
Pedrero V, Bernales M, Chepo M, Manzi J, Pérez M, Fernández P.   +5 more
europepmc   +1 more source

Clinical outcomes of pediatric patients with congenital toxoplasmosis in a fourthlevel center Introduction. Congenital [PDF]

Biomedica
Posada-Bustos S, Mariño AC, Espinosa-García E.   +2 more
europepmc   +1 more source

[Prognosis of patients assisted in the emergency unit by the 'TIA protocol' in a third-level hospital at 90 days]. [PDF]

Rev Neurol, 2022
Marín-Gracia M, López-Bravo A, Jiménez-Jara E, Cantero-Lozano D, Navarro-Pérez MP, Garcés-Antón E, Cueva-Recalde F, Gimeno-Peribáñez MJ, García-Noain A, Tejero-Juste C, Barón-Esquivas G, Pérez-Lázaro C.   +11 more
europepmc   +1 more source

[Our Experience with Pediatric Patients Withdrawn from Pharmacological Treatment for Epilepsy who Remain Untreated]. [PDF]

Rev Neurol
López Pisón J, Gómez Sánchez C, Morte Coscolín P, Fariña Jara MV, Martínez Calvo F, Fernando Martínez R.   +5 more
europepmc   +1 more source

Academic and employment insertion as a factor related to quality of life in patients with drug-resistant temporal lobe epilepsy. [PDF]

Rev Neurol, 2022
Catalán-Aguilar J, Lozano-García A, González-Bono E, Villanueva V, Hampel KG, Cano-López I.   +5 more
europepmc   +1 more source

[Withdrawal and reintroduction of pharmacological treatment of epilepsy in paediatric patients. Our experience]. [PDF]

Rev Neurol
Morte-Coscolín P, Gómez-Sánchez C, López-Pisón J, Fariña-Jara MV, Martínez-Calvo FF, Fernando-Martínez R.   +5 more
europepmc   +1 more source

[[The Future of Clinical Trials]]. [PDF]

Acta Gastroenterol Latinoam
Masson W.
europepmc   +1 more source